STOCK TITAN

Alkermes to Participate in the BofA Securities 2022 Biotech SMID Cap Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Alkermes plc (Nasdaq: ALKS) announced its participation in a fireside chat at the BofA Securities 2022 Biotech SMID Cap Conference, scheduled for December 7, 2022 at 8:00 a.m. ET. The session will be available via webcast on the company's website and archived for 14 days. Alkermes is focused on developing innovative medicines in neuroscience and oncology, with products targeting alcohol and opioid dependence, schizophrenia, and bipolar disorder. The company operates globally with facilities in Dublin, Massachusetts, Ireland, and Ohio.

Positive
  • None.
Negative
  • None.

DUBLIN, Nov. 30, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat as part of the BofA Securities 2022 Biotech SMID Cap Conference on Wednesday, Dec. 7, 2022 at 8:00 a.m. ET (1:00 p.m. GMT). The live webcast may  be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Contact:
Sandy Coombs
Investor Relations
+1 781 609 6377

Alkermes plc Logo (PRNewsfoto/Alkermes plc)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-participate-in-the-bofa-securities-2022-biotech-smid-cap-conference-301689436.html

SOURCE Alkermes plc

FAQ

What is Alkermes participating in on December 7, 2022?

Alkermes will participate in a fireside chat at the BofA Securities 2022 Biotech SMID Cap Conference.

What time is the Alkermes event scheduled for?

The fireside chat is scheduled for 8:00 a.m. ET on December 7, 2022.

Where can I access the Alkermes conference webcast?

The webcast can be accessed under the Investors tab on Alkermes' website.

How long will the Alkermes webcast be available?

The webcast will be archived and available for 14 days.

What areas does Alkermes focus on in its development?

Alkermes develops innovative medicines in neuroscience and oncology, including treatments for addiction and mental health disorders.

Alkermes Inc. plc

NASDAQ:ALKS

ALKS Rankings

ALKS Latest News

ALKS Stock Data

4.77B
169.22M
1.33%
113.13%
9.78%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
DUBLIN 4